Generation of Novel Human Cancer Vaccine | Testing in phase III clinical trials

Parth Patel (u. a.)

ISBN 10: 3659332631 / ISBN 13: 9783659332630

Published by LAP Lambert Academic Publishing, 2013

About this Item

Generation of Novel Human Cancer Vaccine | Testing in phase III clinical trials | Parth Patel (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783659332630 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Seller Inventory # 106083938

Bibliographic Details

• Title: Generation of Novel Human Cancer Vaccine | Testing in phase III clinical trials
• Publisher: LAP Lambert Academic Publishing
• Publication Date: 2013
• Language: English
• ISBN 10: 3659332631
• ISBN 13: 9783659332630
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 150W x 5H x 219D millimeters 150 millimeters width by 5 millimeters height by 219 millimeters depth
• Weight: 190 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Discovery of a potential anticancer therapy is still a challenge to the scientists. Though many different kinds of therapies are developed none of them has lived up to the task to cure cancer completely. Cancer vaccines are found to be the latest discovery in the field of cancer. Although there are number of vaccines undergoing preclinical & clinical trials which are promising to be an effective anticancer therapy. Novel vaccines produce specific immune responses and objective clinical responses with minimal toxicity in phase I/II trials. Advances in gene transfer technology, tumor immunology and better methods of monitoring specific anti tumor immune responses allow the hope that tumor vaccines will be introduced into the clinic, at least in some malignancies resistant to systemic therapy so far such as melanoma and renal cell carcinoma. This book is based on generation of human cancer vaccines that has been tested in phase III clinical trials and shows mechanisms that could contribute to these limited clinical responses, and highlights the challenges faced for development of future vaccines.

About the Author

Parth B. Patel, Masters In Pharmacy (Pharmaceutics) Kalol Institute of Pharmacy, Gujarat Technological University, Gujarat